Clinical trial
Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic…
NCT00118950 · Steno Diabetes Center Copenhagen, Other · Completed
Key facts
| NCT number | NCT00118950 |
|---|---|
| Title | Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet |
| Official title | Effect of Metformin Versus Repaglinide Treatment on Glycemic Control and Non-Glycaemic Cardiovascular Risk Factors in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet |
| Lead sponsor | Steno Diabetes Center Copenhagen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug, Other |
| Interventions | Metformin, Repaglinide, Placebo-Metformin., Placebo-Repaglinide., Diet-only. |
| Enrollment | 100 |
| Start date | Mar 1, 2001 |
| Completion | Mar 1, 2003 |
| First posted | Jul 12, 2005 |
| Last update posted | Dec 8, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: